Nifty 50
- HCL Technologies₹1,326103.00 (8.42%)
- Kotak Mahindra Bank₹439-4.40 (-0.99%)
- TCS₹2,269.30144.30 (6.79%)
- Eternal₹320.45-2.55 (-0.79%)
- Shriram Finance₹98858.60 (6.31%)
- Maruti Suzuki₹11,245-70.00 (-0.62%)
- Tech Mahindra₹1,543.5072.50 (4.93%)
- Max Healthcare₹861-4.95 (-0.57%)
- Infosys₹1,062.1042.10 (4.13%)
- Hindustan Unilever₹1,875.5054.80 (3.01%)
- Bajaj Auto₹10,336302.00 (3.01%)
- Bajaj Finance₹982.7525.50 (2.66%)
- Trent₹2,987.8074.80 (2.57%)
- Adani Enterprises₹2,69565.00 (2.47%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Zydus Lifesciences Share Price Today
As of 14-10-2026 01:10, Zydus Lifesciences Ltd. share price today is ₹0, with a change of ₹-1134.40 (-100.00%) from the previous close of ₹1134.4. The stock opened at ₹1136.1 and traded between ₹1112.3 and ₹1139.8, with a total traded volume of 1113783 shares. The company has a market capitalization of ₹114147.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1232.1 and ₹835.5, respectively.
Zydus Lifesciences Ltd. valuation metrics include a P/E ratio of 25.3, EPS of ₹50.09, and book value of ₹4.10. Profitability indicators show ROE of 18.58% along with a dividend yield of 0.1%. Zydus Lifesciences Ltd. has reported revenue of ₹28591.7 Cr and net profit of ₹4513 Cr.
Zydus Lifesciences Ltd. technical indicators include Day RSI at 46.76, Day MFI at 52.82, Day ADX at 14.26. Additional indicators include Commodity Channel Index (CCI) at -64.2 and Williams %R at -77.1. Momentum indicators show Day MACD at -2.46, Day MACD Signal Line at 3.72, DayATR at 30.96. Rate of Change indicators for Zydus Lifesciences Ltd. include ROC125 at 23.92 and ROC21 at 0.62.
Exponential moving averages include EMA5 at ₹1134.2, EMA10 at ₹1143.8, EMA12 at ₹1145.8, EMA20 at ₹1148.6, EMA26 at ₹1148.3, EMA50 at ₹1140.1, EMA100 at ₹1108.2, EMA200 at ₹1058. Simple moving averages include SMA5 at ₹1135.3, SMA10 at ₹1153.9, SMA20 at ₹1151.8, SMA30 at ₹1150.7, SMA50 at ₹1144.1, SMA100 at ₹1124.8, SMA150 at ₹1055.7, SMA200 at ₹1017.6.
Support levels for Zydus Lifesciences are placed at First Support ₹1114.63, Second Support ₹1094.87, Third Support ₹1082.43. Resistance levels are seen at First Resistance ₹1146.83, Second Resistance ₹1159.27, Third Resistance ₹1179.03. Zydus Lifesciences Ltd. shareholding pattern shows promoter holding at 75.01%, FII holding at 7.05%, DII holding at 0%, public holding at 6.66%.
Zydus Lifesciences Performance
Price Movement
₹1112.30
₹1139.80
1 Year Performance
₹835.50
₹1232.10
Markets Today
Historical Performance
Zydus Lifesciences Fundamentals
Zydus Lifesciences Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 2,872.20 | 3,740.90 | 2,283.60 | 2,871.20 | 2,588.30 |
| Operating Expense | 2,285.20 | 1,751.80 | 2,084.60 | 1,719.30 | 2,002.90 |
| Operating Profit | 587 | 1,989.10 | 199 | 1,151.90 | 585.40 |
| Depreciation | 151.90 | 150.90 | 144.30 | 136 | 130 |
| Interest | 103.10 | 115.50 | 116 | 113.80 | 137.60 |
| Tax | 116.10 | 389 | 55.90 | 287 | 90.20 |
| Net Profit | 339.60 | 1,722 | 296.50 | 1,156.60 | 384.70 |
Zydus Lifesciences Technicals
Zydus Lifesciences Ltd. EMA & SMA
₹1132.50
↗ Bullish Moving Average
6
↘ Bearish Moving Average
10
Zydus Lifesciences Support and Resistance
Resistance
Support
Technical Indicators
Zydus Lifesciences Shareholding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 7.1 | 7.3 | 7.1 | 7 | 6.9 | 7 |
| DII | 11.2 | 10.9 | 11 | 11.2 | 11.3 | 11.3 |
| Public | 6.7 | 6.8 | 6.9 | 6.9 | 6.8 | 6.7 |
Zydus Lifesciences Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 4.33 L | 8.17 L | 53.03% |
| Week | 6.41 L | 12.14 L | 52.85% |
| 1 Month | 8.44 L | 16.59 L | 50.87% |
| 6 Month | 7.72 L | 16.29 L | 47.43% |
Zydus Lifesciences SWOT Analysis
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Stocks near 52 Week High with Significant Volumes
Zydus Lifesciences Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 24 Jul, 2026 | 1 | FINAL | 24 Jul, 2026 | Equity Share |
| 25 Jul, 2025 | 11 | FINAL | 25 Jul, 2025 | Equity Share |
| 26 Jul, 2024 | 3 | FINAL | 26 Jul, 2024 | Equity Share |
| 28 Jul, 2023 | 6 | FINAL | 28 Jul, 2023 | Equity Share |
| 28 Jul, 2022 | 2.5 | FINAL | 29 Jul, 2022 | Equity Share |
| 28 Jul, 2021 | 3.5 | FINAL | Equity Share | |
| 23 Mar, 2020 | 3.5 | INTERIM | 24 Mar, 2020 | Equity Share |
| 25 Jul, 2019 | 3.5 | FINAL | Equity Share | |
| 31 Jul, 2018 | 3.5 | FINAL | Equity Share | |
| 16 Mar, 2017 | 3.2 | INTERIM | 17 Mar, 2017 | Equity Share |
Zydus Lifesciences Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,520 | ₹870.30 | ₹1,460.90 | ₹1,863.70 | ₹2,372 | ₹196.05 |
| % Change | -1.31% | -1.50% | -0.71% | -0.20% | -1.17% | -0.31% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 88.50 | 86.40 | 86.40 | 35.00 | 48.50 | -83.50 |
| 1 Year Return | 217.57 | 10.33 | 70.79 | 31.21 | -2.44 | -2.49 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Similar Stocks
ACUTAAS
Acutaas Chemicals Ltd.
₹ 3197.00
+1.68%
GLAND
Gland Pharma Ltd.
₹ 3088.00
+0.31%
LAURUSLABS
Laurus Labs Ltd.
₹ 2059.40
-0.47%
ALKEM
Alkem Laboratories Ltd.
₹ 5250.00
+0.86%
BIOCON
Biocon Ltd.
₹ 351.00
+1.34%
DIVISLAB
Divi's Laboratories Ltd.
₹ 9285.00
-1.50%
GRANULES
Granules India Ltd.
₹ 815.90
+1.56%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 3321.00
-2.31%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2265.30
-0.78%
WOCKPHARMA
Wockhardt Ltd.
₹ 1981.20
+0.92%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1684.60
-1.31%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1770.70
+0.61%
NEULANDLAB
Neuland Laboratories Ltd.
₹ 20380.00
-0.90%
IPCALAB
Ipca Laboratories Ltd.
₹ 1898.20
-0.09%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2532.00
+0.02%
ABBOTINDIA
Abbott India Ltd.
₹ 25685.00
-0.41%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4642.90
-0.84%
LUPIN
Lupin Ltd.
₹ 1953.60
+0.96%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1240.00
+0.86%
CIPLA
Cipla Ltd.
₹ 1329.60
+1.40%
FAQ's on ZYDUSLIFE
What is the current share price of Zydus Lifesciences Ltd.?
What is the Market Capitalization of Zydus Lifesciences Ltd.?
What are the PE and PB ratios for Zydus Lifesciences Ltd.?
What is the 52-Week High and Low for Zydus Lifesciences Ltd.?
What is the current dividend yield for Zydus Lifesciences Ltd.?
Who are the major shareholders of Zydus Lifesciences Ltd.?
Who are the peers of Zydus Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Zydus Lifesciences Ltd.?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy